• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 10 of 100
Swiss pharma giant Novartis says 30 pipeline drugs with ‘significant potential’ will drive long-term growth
FinanceSwiss pharma giant Novartis says 30 pipeline drugs with ‘significant potential’ will drive long-term growth
By AFPNovember 21, 2024
Fortune Global Forum 2024 Tuesday, November 12, 2024 New York, NY 12:05 PM – 1:20 PM LUNCH STRATEGY SESSIONS PIONEERING TECH THAT DELIVERS NEXT-GEN SOLUTIONS As technology advances, the need to bring new classes of products to customers in both agile and innovative ways becomes crucial. Escalating trade tensions, climate change, geopolitical turmoil, and labor disputes are also throwing traditional commercialization models into disarray. These conflicts are, in turn, putting pressure on production lines, supply chains, and infrastructure, with domino effects across industries and borders. To remain competitive, business leaders must navigate these new complexities in order to deliver everything from life-saving medications to consumer products on time–and at scale. In this session, we’ll learn how some companies have been able to deliver next gen solutions while meeting the demands of a changing marketplace. Presented by Novartis Discussion Leaders: Victor Bulto, President, U.S., Novartis Jennifer Nuckles, Chief Executive Officer, R-Zero Charles van der Steene, President, North America, Maersk Krish Venkataraman, President, Dataiku Moderator: Alex Wood Morton, Fortune Photograph by Michael O’Shea for Fortune
ConferencesFrom biopharma to real estate to shipping, top CEOs insist AI is worth the hype
By Jane ThierNovember 15, 2024
FDA announces new rules to make TV drug ads clearer as Trump nominates RFK Jr., who wants to ban them
HealthFDA announces new rules to make TV drug ads clearer as Trump nominates RFK Jr., who wants to ban them
By Matthew Perrone and The Associated PressNovember 15, 2024
businessman wearing a suit with his arms crossed posed for a photo
NewslettersWhy this major drugmaker no longer has an ‘IT department’
By John KellNovember 13, 2024
Why Eli Lilly’s CEO says failing faster is essential to the company’s success
LeadershipWhy Eli Lilly’s CEO says failing faster is essential to the company’s success
By Fortune EditorsNovember 13, 2024
AstraZeneca says it’s taking China’s investigations into fraud, illegal drug importation and data collection ‘very seriously’
RetailAstraZeneca says it’s taking China’s investigations into fraud, illegal drug importation and data collection ‘very seriously’
By AFPNovember 12, 2024
Robert F. Kennedy Jr. speaks during a campaign rally for Republican presidential nominee, former President Donald Trump at Macomb Community College in Michigan.
PoliticsRFK Jr. could play a big role under Trump—and Big Pharma is sounding the alarm: ‘We need somebody grounded by science and evidence, not somebody who rejects it’
By Christiaan HetznerNovember 8, 2024
AstraZeneca’s China chief detained in illegal data collection and drug import probe, pharma giant says
LeadershipAstraZeneca’s China chief detained in illegal data collection and drug import probe, pharma giant says
By AFPNovember 7, 2024
Many hundred of spectators watch Queen Margrethe of Denmark while the Royal Guard takes her through the city of Kalundborg in a coach during her visit to the city where she commence a two days visit on June 13, 2017 in Kalundborg, Denmark.
LifestyleDanish manufacturing hub of weight-loss wonderdrug Ozempic is an epicenter for childhood overweightedness
By Ryan HoggNovember 4, 2024
Jo Natauri’s Invidia Capital seeks $850 million for first fund
FinanceJo Natauri’s Invidia Capital seeks $850 million for first fund
By Luisa BeltranOctober 31, 2024
British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
RetailBritish pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
By AFPOctober 30, 2024
A hand is seen holding Ozempic.
HealthNovo’s main Ozempic plant cited for quality lapses by FDA
By Madison Muller and BloombergOctober 29, 2024
Top aging expert says these 4 FDA-approved drugs hold promise for extending life
HealthTop aging expert says these 4 FDA-approved drugs hold promise for extending life
By Alexa MikhailOctober 29, 2024
Sanofi profit lifted by early vaccine sales, dupixent growth
FinanceSanofi profit lifted by early vaccine sales, dupixent growth
By Ashleigh Furlong, Tim Loh and BloombergOctober 25, 2024
As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
CommentaryAs activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
By Jeffrey Sonnenfeld and Steven TianOctober 24, 2024
1...
  • 8
  • 9
  • 10
  • 11
  • 12
...100
Most Popular
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Sydney LakeJune 13, 2026
Personal Finance
Current price of oil as of June 12, 2026placeholder alt text
By Joseph HostetlerJune 12, 2026
Environment
Corporate America has been draining the world's water. Matt Damon's new campaign calls on Gap, Starbucks, and Amazon to help give it backplaceholder alt text
By Catherina GioinoJune 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.